Target intelligence / Profile preview

Pulmonary vein-left atrium junction (PV-LA junction)

Target
PV-LA junction
Molecular classification
Other
01

Overview

The pulmonary vein-left atrium (PV-LA) junction is the anatomical region where the four pulmonary veins drain oxygenated blood into the left atrium of the heart (Source: StatPearls, Anatomy, Thorax, Heart Left Atrium). This area is histologically unique due to the presence of myocardial sleeves, which are extensions of atrial muscle that wrap around the proximal portion of the pulmonary veins (Source: Journal of Anatomy, The pulmonary vein-left atrial junction). These sleeves are the most common site for ectopic electrical triggers that initiate and maintain paroxysmal atrial fibrillation (Source: New England Journal of Medicine, Haissaguerre et al., 1998). While the PV-LA junction is not a molecular target like a receptor or enzyme, it is the primary focus of catheter-based ablation procedures, such as pulmonary vein isolation (PVI), which aim to create a conduction block to prevent abnormal impulses from entering the atrium (Source: JACC, Pulmonary Vein Isolation for Atrial Fibrillation). Pharmacological treatments for arrhythmias originating in this region typically target ion channels within the myocytes rather than the junction itself (Source: Circulation, Antiarrhythmic Drugs for Atrial Fibrillation). Therapeutic interventions at this site carry risks such as pulmonary vein stenosis and the rare but life-threatening atrio-esophageal fistula (Source: Heart Rhythm Journal, Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation).

Other names
Pulmonary vein ostiaVeno-atrial junctionPV-LA interfacePulmonary vein-atrial transition zone
02

Mechanism of action

Not a molecular drug target; the junction is targeted via physical ablation (radiofrequency, cryotherapy, or pulsed-field ablation) to achieve electrical isolation of the pulmonary veins from the left atrium.

03

Biological functions

Cardiac electrical conductionPulmonary venous returnOther
04

Disease associations

Cardiovascular diseaseAtrial fibrillationAtrial tachycardiaOther
05

Safety considerations

Pulmonary vein stenosisAtrio-esophageal fistulaPhrenic nerve injuryCardiac tamponadeEsophageal thermal injury
06

Biomarkers

Ectopic triggers on intracardiac electrogramLeft atrial volume index (LAVI)Late gadolinium enhancement MRI (LGE-MRI) for atrial fibrosis

Beyond the preview

Go deeper on Pulmonary vein-left atrium junction (PV-LA junction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmonary vein-left atrium junction (PV-LA junction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call